0.2815
-0.0185
(-6.17%)
At close: January 29 at 1:54:59 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-2,658.1260
-2,347.8910
-3,138.6860
-3,378.6820
-2,774.6310
Financing Cash Flow
2,678.5360
2,147.4290
3,268.2560
3,226.6580
2,991.8420
End Cash Position
22.9920
22.2030
222.6650
93.0950
245.1190
Income Tax Paid Supplemental Data
--
0.9490
19.8980
20.7680
--
Interest Paid Supplemental Data
--
--
--
--
70.3790
Issuance of Capital Stock
1,991.5440
799.9180
--
--
728.3470
Issuance of Debt
676.6720
1,626.9780
3,443.0940
3,907.8200
2,647.5000
Repayment of Debt
-12.5000
--
-146.9120
-328.0880
-346.0000
Free Cash Flow
-2,658.1260
-2,347.8910
-3,138.6860
-3,378.6820
-2,774.6310
12/31/2020 - 5/1/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
YECO EV Biologics, Inc.
0.1010
0.00%
ISCO International Stem Cell Corporation
0.1100
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0024
0.00%
IMUC EOM Pharmaceuticals Holdings, Inc.
0.1600
0.00%
ARTH Arch Therapeutics, Inc.
0.1810
0.00%
ENZN Enzon Pharmaceuticals, Inc.
0.1500
+15.38%
PBLA Panbela Therapeutics, Inc.
0.3252
-14.40%
IGXT IntelGenx Technologies Corp.
0.1700
0.00%
RLMD Relmada Therapeutics, Inc.
0.3540
-2.88%
PXMD PaxMedica, Inc.
0.0310
0.00%